The Food and Drug Administration widened its probe into a serious illness linked to halted clinical trials for AstraZeneca's potential COVID-19 vaccine, sources told Reuters, while in Europe the vaccine approval process has been put on the fast track.
We pledge to do our duty to the best of our ability, independently and without conflicts of interest, and we will be transparent about FDA decisions.
Credit: USATODAY.com - Published 7 hours ago
The earliest a coronavirus vaccine is expected to be ready for FDA authorization is the end of November. The CDC has already given states $200 million to prepare..
Credit: CBS News - Published 14 hours ago
On this "Face the Nation" broadcast, Robert O'Brien and Former FDA Commissioner Scott Gottlieb sat down with Margaret Brennan
Credit: CBS News - Published 2 days ago